𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunosuppressive drug-free operational immune tolerance in human kidney transplants recipients. Part II. Non-statistical gene microarray analysis

✍ Scribed by Victor Sivozhelezov; Christophe Braud; Luca Giacomelli; Eugenia Pechkova; Magali Giral; Jean-Paul Soulillou; Sophie Brouard; Claudio Nicolini


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
372 KB
Volume
103
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Kidney transplant is the reference treatment for patients with end‐stage renal disease, but patients may develop long‐term rejection of the graft. However, some patients do not reject the transplant, but instead are operationally tolerant state despite withdrawal of immunosuppressive treatment. In this second article we outline a microarray‐based identification of key leader genes associated respectively to rejection and to operational tolerance of the kidney transplant in humans by utilizing a non/statistical bioinformatic approach based on the identification of “key genes,” either as those mostly changing their expression, or having the strongest interconnections. A uniquely informative picture emerges on the genes controlling the human transplant from the detailed comparison of these findings with the traditional statistical SAM (Tusher et al. 2001 Proc Natl Acad Sci USA 98:5116–5121) analysis of the microarrays and with the clinical study carried out in the accompanying part I article. J. Cell. Biochem. 103: 1693–1706, 2008. © 2007 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Immunosuppressive drug-free operational
✍ Christophe Braud; Dominique Baeten; Magali Giral; Annaïck Pallier; Joanna Ashton 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 390 KB

## Abstract Survival of solid organ grafts depends on life‐long immunosuppression, which results in increased rates of infection and malignancy. Induction of tolerance to allografts would represent the optimal solution for controlling both chronic rejection (CR) and side effects of immunosuppressio